Crospovidone Storage — Cross-Linked PVP Pharmaceutical Superdisintegrant Tank Selection

Crospovidone Storage — Cross-Linked PVP Pharmaceutical Superdisintegrant Hopper, IBC, and Drum Selection for Tablet Manufacture, ODT, and Solid Dispersions

Crospovidone (CAS 25249-54-1 for the cross-linked form; the conventional CAS 9003-39-8 is shared with linear PVP) is a water-insoluble water-swellable cross-linked homopolymer of N-vinyl-2-pyrrolidone, manufactured by popcorn polymerization in aqueous solution to produce a porous "popcorn" particle morphology. The polymer is one of the three dominant tablet superdisintegrants (alongside croscarmellose sodium and sodium starch glycolate), typically used at 2-5% w/w formulation level, with disintegration mechanism dominated by water-wicking through the porous particle structure plus modest swelling on water uptake. Compared to croscarmellose sodium (sodium-based and hygroscopic) crospovidone offers two functional advantages: lower hygroscopicity (no sodium-cellulose bond to drive moisture pickup, important for moisture-sensitive APIs) and the porous "popcorn" particle structure that acts as a particulate solubility enhancer in suspensions and as a carrier for solid-dispersion solubilization of poorly-soluble APIs. Use levels in modern formulations are typically 2-5% in standard immediate-release tablets, 5-10% in orally disintegrating tablets (ODTs), and 5-30% as solid-dispersion carrier in solubility-challenged API formulations.

This pillar covers the bulk-bag receiving, IBC / drum / hopper storage, and dispensary considerations for crospovidone at the pharmaceutical formulator scale — everything from a 25 kg drum of Kollidon CL in a tablet R&D lab through 1,000-2,000 lb supersacks of Polyplasdone XL feeding a continuous direct-compression line. Citations are to Ashland Specialty Ingredients (Polyplasdone brand including XL standard grade, XL-10 fine-particle ODT grade, INF-10 high-functionality grade, and Polyplasdone Ultra ultra-low-peroxide grade for oxidation-sensitive drug products, manufactured at Texas City TX and Calvert City KY), BASF Pharma Solutions (Kollidon CL family including CL standard grade, CL-F fine grade, CL-M micronized grade, and CL-SF super-fine ODT grade, manufactured at Geismar LA and Ludwigshafen DE), and JH Nanhang as Asia-Pacific alternate. Regulatory citations: USP-NF Crospovidone monograph (Pharmacopeial Discussion Group harmonized), Ph.Eur. Crospovidone, JP Crospovidone, FDA Inactive Ingredient Database, 21 CFR 211 cGMP, ICH Q3D Guideline for Elemental Impurities (R2), USP <232> / <233> elemental impurities, and ICH M7 mutagenic-impurity assessment for residual N-vinyl-2-pyrrolidone monomer.

1. Material Compatibility Matrix

Crospovidone in dry powder form is chemically inert. The polymer is water-insoluble and does not form aqueous solutions; the field application is dry-powder handling and dispensary scaling. Material selection follows pharma cGMP standards.

IBC and hopper construction for crospovidone storage at production scale: 316L body, mechanically polished to 0.5 micron Ra or better on product-contact surfaces, sloped 60-70 degrees from horizontal for mass-flow discharge, full-port butterfly valve at outlet with USP Class VI silicone seat. Bulk silos are LESS common for crospovidone than for MCC because typical formulator usage volume is 100x lower (2-5% vs 30-70% formulation use); IBC and drum-scale handling dominate.

2. Real-World Pharmaceutical Use Cases

Immediate-Release Tablet Superdisintegrant. Polyplasdone XL and Kollidon CL at 2-5% w/w formulation level are alternative superdisintegrants to croscarmellose sodium in immediate-release oral tablets. The selection between crospovidone and CCS depends on API compatibility (crospovidone is preferred for moisture-sensitive APIs and for sodium-restricted formulations), formulation pH constraints (crospovidone is less affected by formulation pH), and processing preferences. Plant-scale inventory at a contract manufacturer typically runs 500-5,000 lb of crospovidone in 25 kg drums or 1,000-2,000 lb supersacks.

Orally Disintegrating Tablets (ODTs). Polyplasdone XL-10 (fine particle size) and Kollidon CL-F / CL-SF (fine and super-fine grades) are the dominant superdisintegrants for orally disintegrating tablets targeting sub-15-second oral-cavity disintegration. The fine particle size + porous structure provides rapid water-wicking on saliva contact, breaking the tablet apart in the mouth without water swallowing. Use levels in ODT formulations are 5-10% w/w. The ODT format is growing at high single-digit annual rate driven by pediatric, geriatric, and dysphagia-patient applications.

Solid-Dispersion Carrier for Poorly-Soluble APIs. Polyplasdone INF-10 and Kollidon CL-M micronized grades are used as porous-carrier matrices for solid-dispersion solubilization of poorly-soluble APIs at 5-30% w/w API loading. The processing typically involves co-melting or co-precipitation of the API with the crospovidone carrier, with the resulting amorphous-API-on-porous-polymer composite providing dramatically enhanced dissolution rate and oral bioavailability for BCS Class II and IV drugs. The application is growing as a complement to spray-dried-dispersion and HME amorphous-dispersion technologies.

Tablet Binder Adjunct. Polyplasdone XL at 1-3% in direct-compression formulations functions as a secondary binder alongside MCC, contributing tablet hardness without requiring wet-granulation processing. Kollidon CL at the same use level provides equivalent function.

Suspension Stabilizer and Disintegrant. Crospovidone at 0.5-2% in oral suspensions and topical creams provides suspension stability via the porous-particle adsorption mechanism, preventing API settling and improving redispersibility on shake. Use in suspensions is formulator-niche but commercially significant for the underlying polymer suppliers.

Oxidation-Sensitive Drug Products (Polyplasdone Ultra). The Polyplasdone Ultra grade from Ashland is an ultra-low-peroxide variant specifically qualified for oxidation-sensitive APIs (most amine-containing drugs, sulfur-containing drugs). The standard crospovidone grades carry typical 200-400 ppm peroxide content from the synthesis process, which can degrade peroxide-sensitive APIs in finished tablets over shelf life. Ultra-grade material is below 100 ppm peroxide and is the supplier-recommended choice for peroxide-sensitive drug products.

3. Regulatory and Pharmacopoeial Compliance

USP-NF Monograph Requirements. The Crospovidone monograph (PDG-harmonized) requires identification by IR or by characteristic insolubility test (the cross-linked polymer is insoluble in water and common organic solvents, distinguishing it from linear PVP), water content not more than 5.0%, residue on ignition not more than 0.4%, water-soluble fraction not more than 1.5%, peroxides not more than 400 ppm (as H2O2), N-vinyl-2-pyrrolidone residual monomer not more than 10 ppm (the same ICH M7 mutagenic-impurity limit as linear PVP), heavy metals not more than 0.001% (replaced by USP <232> / <233> in modern practice), and microbial enumeration per USP <61> / <62>. The USP-NF monograph distinguishes Type A (coarse, 50-180 micron typical) from Type B (fine, <15 micron typical) crospovidone — Polyplasdone XL and Kollidon CL are Type A; Polyplasdone XL-10 and Kollidon CL-F are Type B.

FDA Inactive Ingredient Database. Crospovidone is extensively listed in the IID for oral immediate-release and ODT applications, with maximum-daily-exposure precedent supporting typical 2-10% formulation use levels. The IID listing is the primary regulatory justification for crospovidone selection in new formulations.

ICH M7 Mutagenic Impurity Assessment for N-Vinyl-2-Pyrrolidone. The same NVP-residual concern as linear povidone applies to crospovidone — cross-linking does not eliminate residual NVP monomer. The 10 ppm USP-NF specification translates to PDE-compliant exposure at typical 2-10% formulation use levels. Procurement files for cGMP crospovidone should include the supplier NVP residual COA verification on every lot.

ICH Q3D (R2) Elemental Impurities. Crospovidone is a synthetic polymer with low intrinsic heavy-metal content. Class 1 elements (Cd, Pb, As, Hg) are typically <1 ppm in commercial pharma-grade crospovidone. Procurement files should include supplier elemental-impurity COA as a routine line item.

21 CFR 211 cGMP for Finished Pharmaceuticals. Crospovidone handling falls under 21 CFR 211.80-211.87 component-handling provisions plus 21 CFR 211.166 (stability testing) for peroxide-sensitive APIs. Plant SOPs for peroxide-sensitive drug products should specify Polyplasdone Ultra or equivalent ultra-low-peroxide crospovidone.

OSHA HazCom and Dust Hazards. Dry crospovidone powder is classified as Particulate Not Otherwise Regulated for OSHA respirable-dust PEL of 5 mg/m3 and total-dust PEL of 15 mg/m3. Combustible dust classification under NFPA 654 is moderate; explosion venting per NFPA 68 / 69 applies to deduster and bag-tip operations.

4. Storage System Specification

Drum Storage (25 kg Standard). The dominant crospovidone storage format at the formulator scale is the 25 kg fiber drum with HDPE inner liner, palletized in a temperature- and humidity-controlled raw-material warehouse. Storage conditions per supplier label (typically 25 C / 60% RH or below for cGMP retest interval). Original packaging unopened gives 36-60 month retest period; once opened, lots are typically retested or used within 12 months.

IBC / Supersack Storage (1,000-2,000 lb). High-volume contract manufacturers stage crospovidone in 316L stainless rigid IBCs or in FDA-approved flexible IBCs (FIBCs / supersacks) on pallet racking. The flexible-IBC format requires HDPE inner liner with desiccant pouch and integrity verification at receipt.

Dedicated Bulk Silo (Rare). Very-high-volume operations may justify a dedicated crospovidone silo (5,000-30,000 lb capacity) but this is rare given the 2-10% formulation use level. If a dedicated silo is built, the configuration follows the standard MCC silo design (316L body, electropolished interior, mass-flow cone, dust-cartridge filter, level instrumentation, and bin activator).

Dispensary and Charge-Port. Dispensary scaling of crospovidone at the granulator or blender charge port uses a dedicated crospovidone-only scoop / shovel set, local exhaust ventilation, USP Class VI silicone gasket on the dispensary intake, and operator PPE (N95 respirator, safety glasses, gloves). The lower hygroscopicity of crospovidone (vs croscarmellose sodium) gives modest tolerance for short open-time at the dispensary, but RH-controlled storage is still standard cGMP practice.

Humidity Control. Crospovidone equilibrium moisture content is approximately 3-5% at 50% RH and 8-12% at 80% RH — lower than CCS but still requiring RH-controlled storage. The standard target is 40-60% RH in raw-material warehouse and dispensary spaces.

5. Field Handling Reality

Peroxide Drift on Storage and the Polyplasdone Ultra Decision. Standard-grade crospovidone (Polyplasdone XL, Kollidon CL) carries 200-400 ppm peroxide at release per the USP-NF monograph, with peroxide content typically increasing modestly during long-term storage due to slow oxidative processes. Peroxide-sensitive APIs in finished tablets can be degraded by elevated peroxide content over shelf life, manifesting as elevated impurity formation in stability testing. The formulation development decision — standard crospovidone vs Polyplasdone Ultra ultra-low-peroxide grade — should be made early in formulation design based on API peroxide-sensitivity testing. Procurement files should document the rationale for grade selection.

Type A vs Type B Particle Size. The Type A (coarse, 50-180 micron) and Type B (fine, <15 micron) particle-size distinction is functionally significant: Type A is preferred for direct-compression and wet-granulation tablets where granule disintegration is the target mechanism; Type B (fine) is preferred for ODT and solid-dispersion applications where rapid water-wicking through the porous-particle structure dominates the function. Substituting Type A for Type B (or vice versa) in a marketed product is NOT a like-for-like swap and requires regulatory variation submission. Plant procurement and dispensing SOPs should specify the type designation explicitly.

NVP Monomer Drift on Aging. The same 10 ppm USP-NF specification on N-vinyl-2-pyrrolidone monomer applies to crospovidone as to linear PVP. Aged lots may slowly develop additional NVP from polymer hydrolysis at elevated humidity and temperature. Plant SOPs should verify NVP content on lots from extended storage prior to release-to-use.

Cross-Contamination Control. Crospovidone shares the same dispensary equipment as MCC, lactose, magnesium stearate, and other bulk excipients in most plants. Cross-contamination of a crospovidone lot with iron oxide (from worn carbon-steel scoops) or with magnesium stearate (from inadequate equipment cleaning) can degrade functional performance. Plant SOPs require dedicated crospovidone-only handling equipment and visual cleanliness verification at the dispensary station.

Switching Suppliers. Polyplasdone XL and Kollidon CL are nominally interchangeable at the USP-NF monograph level but differ in particle-size distribution, porosity, and peroxide content. Switching crospovidone supplier in an ANDA-filed product typically requires regulatory variation and disintegration / dissolution bioequivalence assessment. Plant procurement should NOT switch crospovidone source without RA / formulation review.

Related Chemistries in the Organic Acid Cluster

Related chemistries in the organic acid cluster (food + pharma + cleaning + preservative + biodegradable chelation + protein carboxylate + anionic / amphoteric / nonionic surfactant + hydrotrope + cellulose-derivative excipient + polysaccharide + sugar carbohydrate excipient chemistry):

• Povidone (PVP) — Parent PVP polymer chemistry
• Croscarmellose Sodium — Crosslinked superdisintegrant sister chemistry
• HPMC (Hypromellose) — Polymer excipient companion chemistry
• PEG 4000 — Polymer excipient companion chemistry
• Microcrystalline Cellulose (MCC) — Tablet excipient companion chemistry

Related Hub Pillars

For broader chemistry context, see the OneSource Plastics high-traffic chemical-compatibility hub pillars:

• Sulfuric Acid (H₂SO₄)
• Hydrochloric Acid (HCl / muriatic)
• Sodium Hydroxide (NaOH / caustic soda)